COVID-19 Causes Autoimmune Surge, ESGCT 2024 Showcases Gene Therapy, Researchers Unveil Gene Motion Insights, Study Links 254 Genetic Variants, and more...

(0:10): COVID-19's Lasting Impact: Surge in Autoimmune Disorders, Brain Fog, and Remote Work Trends(1:58): Breakthroughs in Gene Therapy: ESGCT 2024 to Showcase Innovations in CNS and Cardiomyopathy Treatments(4:13): NYU Researchers Unveil Gene Motion Insights: Key to Understanding Cancer and Cardiovascular Disorders(6:26): Global Study Unveils 254 Genetic Variants Linked to Brain Disorders like ADHD and Parkinson's(8:23): Graphene Turns 20: Transformative Material Nears Breakthrough in Construction, Biomedicine, and EnergyTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: News-Medical